✦ LIBER ✦
Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome
✍ Scribed by G. Derosa; A. D'Angelo; P. D. Ragonesi; L. Ciccarelli; M. N. Piccinni; F. Pricolo; S. A. T. Salvadeo; L. Montagna; A. Gravina; I. Ferrari; S. Paniga; A. F. G. Cicero
- Book ID
- 108848968
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 116 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0269-4727
No coin nor oath required. For personal study only.